Tricuspid TEER Continues to Improve QoL, Severity of TR, HF Hospitalization Rates: 2-Year TRILUMINATE Study Update

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650 Annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

Tricuspid TEER Continues to Improve QoL, Severity of TR, HF Hospitalization Rates: 2-Year TRILUMINATE Study Update

Posted: 03/30/2025
Author:
Bailey G. Salimes, CRTonline.org
Conference Tricuspid Valve interventions Transcatheter Edge-to-Edge Repair Heart Failure Valve & Structural 2025 News Articles ACC

At 2-years, tricuspid transcatheter edge-to-edge repair (TEER) is safe and significantly reduces the severity of tricuspid regurgitation (TR) and rates of heart failure hospitalization (HFH) compared to medical therapy alone in patients with severe, symptomatic tricuspid regurgitation.
1-3 of 2860 results
1 2 3 4 5 Next »

EARLY TAVR Sub-Analysis Shows Benefits of Early TAVR Regardless of Baseline Biomarker Levels

Mar 31, 2025 by
Bailey G. Salimes, CRTonline.org

Patients with severe, asymptomatic aortic stenosis (AS) benefit from early transcatheter aortic valve replacement (TAVR) regardless of baseline cardiac biomarker levels, but these benefits are more pronounced in patients with lower levels of biomarkers, a sub-analysis of the EARLY TAVR trial shows.

Balloon Angioplasty Guided by IVI Before Stent Implantation Effective for Severely Calcified Lesions: ECLIPSE Trial

Mar 31, 2025 by
Bailey G. Salimes, CRTonline.org

At 1-year, minimal stent area does not increase, and target vessel failure does not decrease, with the use of routine orbital atherectomy pre-drug-eluting stent (DES) implantation compared with using a balloon angioplasty approach in patients with severely calcified lesions, the ECLIPSE trial shows.

Patients With Severe, Asymptomatic AS, AVS and Delayed AVR Show Worse Clinical Outcomes Than Early TAVR Patients: EARLY TAVR Sub-Analysis

Mar 31, 2025 by
Bailey G. Salimes, CRTonline.org

Acute valve syndrome (AVS) plus delayed aortic valve replacement (AVR) is associated with a higher risk of death, stroke or heart failure hospitalization (HFH) in patients with severe aortic stenosis (AS) within 2 years after the procedure, compared with early transcatheter aortic valve replacement (TAVR), a sub-analysis of the EARLY-TAVR trial shows.

1-3 of 2860 results
1 2 3 4 5 Next »

Most Viewed Pages

EARLY TAVR Sub-Analysis Shows Benefits of Early TAVR Regardless of Baseline Biomarker Levels

EKSTROM Trial Shows Reduction of Plaque Volume Progression in Patients With CAD Taking Colchicine

Patients With Severe, Asymptomatic AS, AVS and Delayed AVR Show Worse Clinical Outcomes Than Early TAVR Patients: EARLY TAVR Sub-Analysis

Balloon Angioplasty Guided by IVI Before Stent Implantation Effective for Severely Calcified Lesions: ECLIPSE Trial

Early Outcomes of Transjugular Transcatheter Tricuspid Valve Replacement

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

Tricuspid TEER Continues to Improve QoL, Severity of TR, HF Hospitalization Rates: 2-Year TRILUMINATE Study Update

EARLY TAVR Sub-Analysis Shows Benefits of Early TAVR Regardless of Baseline Biomarker Levels

Balloon Angioplasty Guided by IVI Before Stent Implantation Effective for Severely Calcified Lesions: ECLIPSE Trial

Patients With Severe, Asymptomatic AS, AVS and Delayed AVR Show Worse Clinical Outcomes Than Early TAVR Patients: EARLY TAVR Sub-Analysis

Most Viewed Pages

Explore the Site

Stay Connected